22 June 2016, Bellingham, WA Affirmativ Health, PLLC (http://www.affirmativhealth.com) has signed a license agreement with the Buck Institute for Research on Aging (Buck) to offer educational immersion workshops for sufferers of mild cognitive impairment (MCI), early stage Alzheimer’s disease (AD), and other early stage dementia types. Affirmativ Health will offer the RE:Mind workshop originally developed at Buck, leveraging their pioneering Alzheimer’s research as the foundation of the program. The initial RE:Mind workshop offered by Affirmativ Health will take place June 27 in Sonoma, CA.
Former Buck VP of Cognitive Wellness, Denise Kalos has joined Affirmativ Health as COO to continue efforts to expand access to the innovative RE:Mind workshop. Kalos comments, “I’m excited to join Affirmativ Health. Our team is poised to build on the strong foundation of the RE:Mind workshops already completed and to significantly expand our ability to offer the program around the country and, ultimately, to the rest of the world.” The RE:Mind workshop employs a personalized approach to the multiple metabolic and genetic facets of an individual’s cognitive health, and focuses primarily on education and lifestyle adjustments.
Ryan Fortna, MD PhD, a pathologist whose PhD work was focused on the cell biology of Alzheimer’s disease, will serve as Scientific Director of Affirmativ Health. He states, “Despite years of intense research efforts and significant progress on the understanding of the underlying pathologic basis of Alzheimer’s disease, very little progress has been made on the therapeutic side by standard medical approaches. While much of the medical community has ignored alternative approaches, there is growing evidence that lifestyle modifications, metabolic optimization, and other non-pharmaceutical approaches provide significant benefit for sufferers of early cognitive impairment, with results that are in many ways more impressive than traditional approaches. I am excited to be a part of the effort to bring this information to the public.”
Neuropathologist John W. Hoyt, M.D. will present a segment of RE:Mind in June. “Although no effective drug treatment has been discovered to prevent these dementias, the health and lifestyle changes taught in these workshops have proven beneficial in enhancing the neuroplasticity of the brain (i.e. its ability to re-wire itself), and reversing or slowing cognitive decline.”
Affirmative Health officially opened its doors on 9 May 2016 and is headquartered in Bellingham, WA.
About Affirmativ Health: Affirmativ Health is passionate about bringing education, wellness, and hope to those who are affected by Alzheimer’s disease and other cognitive disorders. We seek to bring the latest health-conscious science to those with early stage cognitive decline or genetic predispositions for these disorders. We do this by educating and supporting these individuals, utilizing the most recent scientific knowledge on diet, lifestyle and other key factors for maximizing brain health and fighting the effects of neurodegenerative disease
About the Buck Institute for Research on Aging: The Buck Institute is the nation’s first independent research facility focused solely on understanding the connection between aging and chronic disease. Our mission is to increase the healthy years of life.
At the Buck Institute, world-class scientists work in a uniquely collaborative environment to understand how normal aging contributes to the development of conditions specifically associated with getting older such as Alzheimer’s and Parkinson’s diseases, cancer, stroke, osteoporosis, heart disease, diabetes, macular degeneration and glaucoma. Our interdisciplinary approach brings scientists from disparate fields together to develop diagnostic tests and treatments to prevent or delay these maladies.
The stakes have never been higher. While it’s true that people are living longer, those “extra” years are often marked by disability and pain. In addition to personal hardship, there is also a cost to society. The financial burden of treating the chronic diseases of aging is expected to rise steadily as Baby Boomers get older. There is an urgency to our mission.
Unlike traditional universities, which have departmental boundaries and large bureaucracies, the Buck Institute is designed for the free flow of information. Discoveries quickly result in new studies. Scientists studying breast cancer are collaborating with researchers examining aging and nutrition. Parkinson’s disease is being studied in three different model organisms. A unique inquiry into stem cells and aging is underway. It’s an exciting place for science that has the potential to change the way we live.